Skip to main content
. 2018 Mar 17;71(8):702–707. doi: 10.1136/jclinpath-2018-205000

Figure 3.

Figure 3

Molecular classification of glioblastomas (GBMs). We separated GBMs into three groups: ATRX/IDH1R132H, high p-Hsp27 expression (p-Hsp27+) and none of these three markers. Individuals with ATRX/IDH1R132Hshowed the longest median survival, those with high p-Hsp27 expression had an intermediate prognosis, and those without any alteration in the three proteins had the poorest survival rates.